Identification of a Gene Expression Profile That Differentiates Between Ischemic and Nonischemic Cardiomyopathy
暂无分享,去创建一个
G. Parmigiani | R. Irizarry | Jennifer L Hall | S. Ye | J. Garcia | L. Miller | J. Hare | J. Conte | M. Kittleson | Khalid M. Minhas | Gina Edness | Yingjie Chen | Joe G. N. Garcia | Jennifer L. Hall
[1] Xinqiang Han,et al. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. , 2004, Physiological genomics.
[2] Stefan Kääb,et al. Global gene expression in human myocardium—oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure , 2004, Journal of Molecular Medicine.
[3] Edison T Liu,et al. Microarrays and clinical investigations. , 2004, The New England journal of medicine.
[4] R. Tibshirani,et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. , 2004, The New England journal of medicine.
[5] R. Verhaak,et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.
[6] Raimond L Winslow,et al. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. , 2004, Genomics.
[7] J. Miyazaki,et al. cDNA Array Hybridization Reveals Cardiac Gene Expression in Acute Ischemic Murine Hearts , 2001, Cardiovascular Drugs and Therapy.
[8] M. Josephson,et al. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. , 2003, Circulation.
[9] Euan A Ashley,et al. Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac Dysfunction , 2003, Circulation.
[10] M. Hori,et al. Canine DNA array as a potential tool for combining physiology and molecular biology. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[11] L. Miller,et al. Alterations of gene expression in failing myocardium following left ventricular assist device support. , 2003, Physiological genomics.
[12] L. Kedes,et al. Gene expression profiling--a new approach in the study of myocardial ischemia. , 2003, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[13] James Fang,et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. , 2003, Journal of the American College of Cardiology.
[14] W. Koch,et al. Differential gene expression and genomic patient stratification following left ventricular assist device support. , 2003, Journal of the American College of Cardiology.
[15] Christopher M O'Connor,et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. , 2003, Journal of the American College of Cardiology.
[16] E. Lakatta,et al. Sex- and age-dependent human transcriptome variability: Implications for chronic heart failure , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] C. D. dos Remedios,et al. Activation of signal transducer and activator of transcription (STAT) pathways in failing human hearts. , 2003, Cardiovascular research.
[18] M. Le Cunff,et al. Transcriptomal analysis of failing and nonfailing human hearts. , 2003, Physiological genomics.
[19] M. Radmacher,et al. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. , 2003, Journal of the National Cancer Institute.
[20] Sayan Mukherjee,et al. Estimating Dataset Size Requirements for Classifying DNA Microarray Data , 2003, J. Comput. Biol..
[21] Atul Butte,et al. The use and analysis of microarray data , 2002, Nature Reviews Drug Discovery.
[22] S. Cook,et al. DNA Microarrays : Implications for Cardiovascular Medicine , 2002 .
[23] D. Latchman,et al. Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. , 2002, American journal of physiology. Heart and circulatory physiology.
[24] Y. Ladilov,et al. Role of protein phosphatases in hypoxic preconditioning. , 2002, American journal of physiology. Heart and circulatory physiology.
[25] Jianbo Li,et al. The gene expression fingerprint of human heart failure , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] George C Tseng,et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. , 2002, Physiological genomics.
[27] L. Staudt,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[28] Paul D Allen,et al. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. , 2002, The American journal of pathology.
[29] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[30] C. O'connor,et al. A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.
[31] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[32] M. Drazner,et al. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. , 2001, Journal of the American College of Cardiology.
[33] Towbin Ja,et al. Molecular genetics of left ventricular dysfunction. , 2001 .
[34] J. Towbin,et al. Molecular genetics of left ventricular dysfunction. , 2001, Current molecular medicine.
[35] D. Lyn,et al. Gene expression profile in mouse myocardium after ischemia. , 2000, Physiological genomics.
[36] R H Hruban,et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.
[37] S. Vanni,et al. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart. , 2000, Circulation research.
[38] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[39] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[40] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] F. Follath,et al. Etiology and response to drug treatment in heart failure. , 1998, Journal of the American College of Cardiology.
[42] C. di Loreto,et al. Myocyte proliferation in end-stage cardiac failure in humans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.